Tonghua Golden-Horse Pharmaceutical's Q3 Profit Surges 140%

MT Newswires Live10-22

Tonghua Golden-Horse Pharmaceutical's (SHE:000766) attributable profit rose 140% year over year to 11.5 million yuan in the third quarter, according to a Tuesday filing with the Shenzhen Stock Exchange.

EPS at the pharmaceutical company increased 143% year over year to 0.0119 yuan.

Operating income grew 1.2% year over year to 319.4 million yuan.

Shares jumped 1% during Tuesday's trading.

Price (RMB): ¥15.74, Change: ¥+0.21, Percent Change: +1.35%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment